SEATTLE — Use of a new protocol — sequential beta-hydroxybutyrate testing with a cut-off for ruling out insulinoma in patients with hypoglycemia — may allow for a shortening of the gold-standard ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results